Key facts
- This page summarizes Omar Khwaja's Form 4 filing for Voyager Therapeutics, Inc. (VYGR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 May 2021, 16:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on May 20, 2021. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.
SEC remarks
Chief Medical Officer and Head of Research & Development.